JP2004191367A5 - - Google Patents

Download PDF

Info

Publication number
JP2004191367A5
JP2004191367A5 JP2003396384A JP2003396384A JP2004191367A5 JP 2004191367 A5 JP2004191367 A5 JP 2004191367A5 JP 2003396384 A JP2003396384 A JP 2003396384A JP 2003396384 A JP2003396384 A JP 2003396384A JP 2004191367 A5 JP2004191367 A5 JP 2004191367A5
Authority
JP
Japan
Prior art keywords
fibrinogen
reagent
inhibitor
thrombin
reagent kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003396384A
Other languages
Japanese (ja)
Other versions
JP2004191367A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2003396384A priority Critical patent/JP2004191367A/en
Priority claimed from JP2003396384A external-priority patent/JP2004191367A/en
Publication of JP2004191367A publication Critical patent/JP2004191367A/en
Publication of JP2004191367A5 publication Critical patent/JP2004191367A5/ja
Pending legal-status Critical Current

Links

Claims (8)

トロンビンと抗トロンビン作用を有する阻害剤を含有するフイブリノゲン定量用試薬。 A reagent for quantifying fibrinogen containing thrombin and an inhibitor having an antithrombin action. 阻害剤が抗トロンビン作用を有するプロテアーゼ拮抗剤である請求項１に記載のフイブリノゲン定量用試薬。 The reagent for quantifying fibrinogen according to claim 1, wherein the inhibitor is a protease antagonist having an antithrombin action. カルシウムイオン及び有機酸を含有する請求項１に記載のフイブリノゲン定量用試薬。 The reagent for quantitative determination of fibrinogen according to claim 1, comprising calcium ions and an organic acid . 界面活性剤及びタンパク質からなる群から選択される化合物を含有する請求項１〜３のいずれか１項に記載のフイブリノゲン定量試薬。 The fibrinogen quantitative reagent according to any one of claims 1 to 3, comprising a compound selected from the group consisting of a surfactant and a protein . 検体希釈用緩衝液とトロンビン試薬を含むフイブリノゲン定量用試薬キットであって、トロンビン試薬はトロンビンおよび抗トロンビン作用を有する阻害剤を含むことを特徴とするフイブリノゲン定量用試薬キット。 A fibrinogen quantification reagent kit comprising a buffer and a thrombin reagent sample dilution, thrombin reagent fibrinogen quantification reagent kit which comprises an inhibitor with thrombin and antithrombin activity. 阻害剤が抗トロンビン作用を有するプロテアーゼ拮抗剤である請求項５に記載のフイブリノゲン定量用試薬キット。 The reagent kit for fibrinogen quantification according to claim 5, wherein the inhibitor is a protease antagonist having an antithrombin action. カルシウムイオン及び有機酸を含有する請求項６に記載のフイブリノゲン定量用試薬キット。 The reagent kit for fibrinogen determination according to claim 6, comprising calcium ions and an organic acid . 界面活性剤及びタンパク質からなる群から選択される化合物を含有する請求項５〜７のいずれか１項に記載のフイブリノゲン定量用試薬キット。 The reagent kit for fibrinogen determination according to any one of claims 5 to 7, comprising a compound selected from the group consisting of a surfactant and a protein .
JP2003396384A 2002-11-28 2003-11-26 Thrombin reagent and test reagent kit Pending JP2004191367A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003396384A JP2004191367A (en) 2002-11-28 2003-11-26 Thrombin reagent and test reagent kit

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002345532 2002-11-28
JP2003396384A JP2004191367A (en) 2002-11-28 2003-11-26 Thrombin reagent and test reagent kit

Publications (2)

Publication Number Publication Date
JP2004191367A JP2004191367A (en) 2004-07-08
JP2004191367A5 true JP2004191367A5 (en) 2006-12-28

Family

ID=32774855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003396384A Pending JP2004191367A (en) 2002-11-28 2003-11-26 Thrombin reagent and test reagent kit

Country Status (1)

Country Link
JP (1) JP2004191367A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1637141T3 (en) 2004-09-21 2012-04-30 Trobio Ab Stabilized protease composition comprising a serine protease, morpholino derivatives and reversible inhibitors of said serine protease
AU2005336535B2 (en) * 2005-09-22 2012-05-24 Trobio Ab Stabilized protease composition
CN101558310B (en) 2006-12-21 2013-05-08 积水医疗株式会社 Method for stabilizing a-thrombin in thrombin-containing solution
JP4999613B2 (en) * 2007-08-31 2012-08-15 シスメックス株式会社 Blood coagulation measurement reagent and blood coagulation time measurement method
WO2010134345A1 (en) * 2009-05-20 2010-11-25 積水メディカル株式会社 Blood coagulation time prolonging agent
JP2011069718A (en) * 2009-09-25 2011-04-07 Sekisui Medical Co Ltd Blood coagulation time extension agent in blood coagulation reaction
GB2492104A (en) * 2011-06-22 2012-12-26 Job Harenberg Assay for direct thrombin inhibitors
CN103764028B (en) 2011-07-05 2016-08-24 贝克顿·迪金森公司 Solidification controlling agent and the device comprising solidification controlling agent
JP2013145238A (en) * 2013-03-04 2013-07-25 Sekisui Medical Co Ltd Blood coagulation time extension reagent in blood coagulation reaction
JP2014197019A (en) * 2014-06-30 2014-10-16 積水メディカル株式会社 Blood coagulation time extension reagent in blood coagulation reaction
JP6058726B2 (en) * 2015-03-30 2017-01-11 積水メディカル株式会社 Blood coagulation time extender in blood coagulation reaction

Similar Documents

Publication Publication Date Title
JP2004191367A5 (en)
EP1379693A4 (en) Bio-barcodes based on oligonucleotide-modified particles
ATE431854T1 (en) DETECTION OF TARGET ANALYTES BASED ON BIO-BARCODES
ATE300054T1 (en) METHOD, REAGENT, MEASURING CARTRIDGE AND DEVICE FOR DETERMINING FIBRINOGEN
NO20025371L (en) Improvements to fluorescence polymer-QTL approach for bio-detection
IL217489A (en) Modified urinary plasminogen activator (u-p a) polypeptides with altered substrate specificity or activity and compositions and uses thereof
ATE517341T1 (en) INTERLEUKIN-33 (IL-33) FOR THE DIAGNOSIS AND PREDICTION OF CARDIOVASCULAR DISEASES
EA200400329A1 (en) METHODS OF NUCLEIC ACID AMPLIFICATION
WO2008041953A3 (en) Dengue diagnosis and treatment
ATE331960T1 (en) DIAGNOSIS OF MYOCARDIAL INFARCTION AND ACUTE CORONARY SYNDROME BY COMBINATION OF MARKERS
ATE335850T1 (en) REAL-TIME QUANTIFICATION WITH INTERNAL STANDARDS
ATE449337T1 (en) ASSAY
US20090087870A1 (en) Hematological assay and kit
NO20054119L (en) Chemical treatment of biological samples for nucleic acid extraction and kits for this
BRPI0607912A2 (en) Assay for the presence, absence, or health of a cell, analyte, nucleic acid, or microorganism in a sample, probe, methods for selecting an analyte that binds to a compound to determine whether a nucleic acid of interest interacts with a interest in a cell or sample, and to determine the presence or absence of one or more target compounds in a sample, kit for staining cells, analytes, nucleic acids or microorganisms in a sample, and, "
EP2529221B1 (en) Thrombin generation determination method
ATE368229T1 (en) DIAGNOSTIC TEST FOR DETERMINING THE CONCENTRATION OF TRANSIENT PROTEOLYTIC ACTIVITY IN COMPOSITE BIOLOGICAL MEDIA
ATE294392T1 (en) REAGENT FOR DETERMINING PLATETIC MICROPARTICLES
WO2003098185A3 (en) Systems and methods for identifying organ transplant risk
EP0927767A3 (en) Improved thrombin-based assay for antithrombin-III
DE60310012D1 (en) Method, assay and kit for the quantification of HIV protease inhibitors
JP2009204612A5 (en)
JP2005520170A5 (en)
EA200801476A1 (en) SUBSTITUTED AMINOPHENYL SULPHONAMIDE COMPOUNDS AS HIV PROTEASE INHIBITORS
WO2005111231A3 (en) Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities